Erasmus School of Health Policy & Management (ESHPM) together with the Cancer Institute of Erasmus Medical Centre is dedicated to advancing research on healthcare systems and policy. We are offering an exciting PhD opportunity focusing on the centralization of oncology care (specifically secondary metastatic colorectal cancer) and its potential effects on accessibility, treatment quality, and patient outcomes in the Netherlands and beyond.
This data-driven project will use real-world data to examine how centralization affects equity in access, treatment patterns, and the integration of complex technologies. The successful candidate will have strong data-driven methodological learning opportunities with high social impact on cancer care organisation. They will work within an interdisciplinary team, applying advanced modeling techniques and analyzing large-scale datasets to contribute to healthcare policy decisions.
The PhD project will be supervised by Dr. Nora Franzen and Professor Maarten J. IJzerman in collaboration with Professor Henk Verheul (medical oncology) and Professor Kees Verhoef (oncologic surgery). Join our team if you are passionate about improving cancer care by investigating healthcare systems, addressing inequalities, and contributing to impactful, data-driven research with a global perspective.
Job descriptionThis PhD project will explore the impact of centralizing specialized Colorectal Cancer (CRC) care and its consequences on equitable access to high-quality cancer treatment. The research will use data-driven methodologies to analyze how the organization of oncology care can be improved. The primary focus will be on the Netherlands, with comparisons to other countries and regions, including Europe and Australia. Special attention will be given to the surgical and medical management of patients with low volume CRC (e.g. colon) or those with secondary metastatic sites following primary CRC treatment (e.g. liver and lung metastases). This (low-volume) complex care requires further concentration in specialized clinics with access innovative treatments and technologies, such as (hybrid) surgical equipment, cell therapies, AI-driven methods, and advanced genomics.
The project will focus on the following key questions:
-
Analysing Centralization and Accessibility: Using population data from real world data sources such as cancer registries and data from the central bureau of statistics, the PhD student will analyze how centralization of oncology care influences accessibility, focusing on high complex interventional procedures for CRC patients. This includes assessing levels of centralization, patient travel times, regional variations, and treatment patterns.
-
Simulation Modelling: The candidate will develop and apply simulation models to evaluate the effects of centralizing care on measures such as healthcare capacity, patient outcomes, travel distances, and access to innovative and complex treatments.
-
Patient Preferences: The PhD student will investigate how patients (e.g. using discrete choice experiments or similar methods) perceive the centralization of oncology care, considering their preferences for access to specialized treatments and the impact of technological advancements.
The PhD student will utilize real-world data (RWD) to analyze patterns of care delivery, outcomes, and system-level inefficiencies. The results will inform policy decisions aimed at improving the quality, equity, and efficiency of cancer care, with a focus on ensuring sustainability and maximizing the benefits of new technologies.